Ontology highlight
ABSTRACT: Objective
Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients with LN.Methods
Patients with LN during 2010 to 2020 in Queen Mary Hospital and Pamela Youde Nethersole Eastern Hospital were included in the discovery cohort and validation cohort, respectively. Complete renal response (CRR), partial renal response (PRR), LLDAS, and Definition Of Remission In SLE (DORIS) remission were assessed at 12 months. Regression analysis was performed to identify risk factors of LN relapse. Receiver ope
SUBMITTER: Cheung CK
PROVIDER: S-EPMC12919694 | biostudies-literature | 2026 Feb
REPOSITORIES: biostudies-literature